Home >> Signaling Pathways >> Ubiquitination/ Proteasome

Ubiquitination/ Proteasome

Products for  Ubiquitination/ Proteasome

  1. Cat.No. Product Name Information
  2. GC30761 α-Hydroxylinoleic acid α-Hydroxylinoleic acid (α-Hydroxylinoleic acid) induces endoplasmic reticulum (ER) stress-mediated autophagy. α-Hydroxylinoleic acid  Chemical Structure
  3. GC46008 (±)-Thalidomide-d4


    An internal standard for the quantification of (±)-thalidomide (±)-Thalidomide-d4  Chemical Structure
  4. GC34960 (+)-Talarozole (+)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1. (+)-Talarozole  Chemical Structure
  5. GC10603 (-)-epicatechin gallate


    major catechin in green tea (-)-epicatechin gallate  Chemical Structure
  6. GC17242 (-)-epigallocatechin

    (-)EGC, epi-Gallocatechin, NSC 674039

    green tea epicatechin (-)-epigallocatechin  Chemical Structure
  7. GC14049 (-)-Epigallocatechin gallate (EGCG)


    (-)-Epigallocatechin Gallate sulfate (EGCG) is a major polyphenol in green tea that inhibits cell proliferation and induces apoptosis. In addition, it inhibits the activity of glutamate dehydrogenase 1/2 (GDH1/2, GLUD1/2) .. (-)-Epigallocatechin gallate (EGCG)  Chemical Structure
  8. GC31386 (-)-PX20606 trans isomer ((-)-PX-102 trans isomer) (-)-PX20606 trans isomer ((-)-PX-102 trans isomer) is a FXR agonist with EC50s of 18 and 29 nM for FXR in FRET and M1H assay, respectively. (-)-PX20606 trans isomer ((-)-PX-102 trans isomer)  Chemical Structure
  9. GC65547 (1S,2R)-Alicapistat


    (1S,2R)-Alicapistat ((1S,2R)-ABT-957) is an orally active selective inhibitor of human calpains 1 and 2 for the potential application of Alzheimer's disease (AD). (1S,2R)-Alicapistat  Chemical Structure
  10. GC62193 (1S,2S)-Bortezomib (1S,2S)-Bortezomib is an enantiomer of Bortezomib. Bortezomib is a cell-permeable, reversible, and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki of 0.6 nM) by targeting a threonine residue. Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF-κB. Bortezomib is an anti-cancer agent and the first therapeutic proteasome inhibitor to be used in humans. (1S,2S)-Bortezomib  Chemical Structure
  11. GC60395 (3S,5R)-Fluvastatin D6

    (3S,5R)-XU 62-320 free acid D6

    (3S,5R)-Fluvastatin D6 is the deuterium labeled (3S,5R)-Fluvastatin sodium. (3S,5R)-Fluvastatin D6  Chemical Structure
  12. GC49189 (E/Z)-4-hydroxy Tamoxifen-d5

    Afimoxifene-d5, 4-OHT-d5

    An internal standard for the quantification of (E/Z)-4-hydroxy tamoxifen (E/Z)-4-hydroxy Tamoxifen-d5  Chemical Structure
  13. GC34096 (R)-(-)-Gossypol acetic acid (AT-101 (acetic acid)) (R)-(-)-Gossypol acetic acid (AT-101 (acetic acid)) (AT-101 (acetic acid)) is the levorotatory isomer of a natural product Gossypol. AT-101 is determined to bind to Bcl-2, Mcl-1 and Bcl-xL proteins with Kis of 260±30 nM, 170±10 nM, and 480±40 nM, respectively. (R)-(-)-Gossypol acetic acid (AT-101 (acetic acid))  Chemical Structure
  14. GC31665 (R)-BPO-27 (R)-BPO-27, the R enantiomer of BPO-27, is a potent, orally active and ATP-competitive CFTR?inhibitor with an?IC50 of 4 nM. (R)-BPO-27  Chemical Structure
  15. GC41233 (R)-MG132

    A potent proteasome inhibitor

    (R)-MG132  Chemical Structure
  16. GC62528 (Rac)-Hesperetin (Rac)-Hesperetin is the racemate of Hesperetin. (Rac)-Hesperetin  Chemical Structure
  17. GC13136 (S)-Crizotinib Potent MTH1 inhibitor (S)-Crizotinib  Chemical Structure
  18. GC14820 (S)-Naproxen

    CG 3117, (S)-Naproxen

    (S)-Naproxen is a COX-1 and COX-2 inhibitor with IC50s of 8.72 and 5.15 μM, respectively in cell assay. (S)-Naproxen  Chemical Structure
  19. GC15015 (±)-Bay K 8644

    SQ 28,873

    L-type Ca2+-channel activator (±)-Bay K 8644  Chemical Structure
  20. GC35068 1-Monomyristin

    MG(14:0/0:0/0:0), 1-Monomyristin

    A monoacylglycerol 1-Monomyristin  Chemical Structure
  21. GC17295 10058-F4 C-Myc-Max dimerization inhibitor 10058-F4  Chemical Structure
  22. GC14918 10074-G5 c-Myc inhibitor 10074-G5  Chemical Structure
  23. GC11720 17-AAG (KOS953)

    BMS 722782, CP 127374, KOS 953, NSC 330507, Tanespimycin

    An inhibitor of Hsp90 17-AAG (KOS953)  Chemical Structure
  24. GC40947 2,3-Dimethoxy-5-methyl-p-benzoquinone

    Coenzyme Q0, CoQ0

    2,3-Dimethoxy-5-methyl-p-benzoquinone (CoQ0) is a potent, oral active ubiquinone compound can be derived from Antrodia cinnamomea. 2,3-Dimethoxy-5-methyl-p-benzoquinone  Chemical Structure
  25. GC46057 2,5-Dihydroxycinnamic Acid phenethyl ester An inhibitor of 5-LO 2,5-Dihydroxycinnamic Acid phenethyl ester  Chemical Structure
  26. GC15084 2-Methoxyestradiol (2-MeOE2)

    2Hydroxyestradiol 2methyl ether, 2ME2, NSC 659853, Panzem

    2-Methoxyestradiol (2-MeOE2/2-Me) is a HIF-1α inhibitor that inhibits HIF-1α accumulation and HIF transcriptional activity. 2-Methoxyestradiol can trigger p53-induced apoptosis and has potential antitumor activity.. 2-Methoxyestradiol (2-MeOE2)  Chemical Structure
  27. GC30011 20-Deoxyingenol A diterpenoid with antioxidant and osteoprotective activities 20-Deoxyingenol  Chemical Structure
  28. GC68503 20S Proteasome activator 1

    20S Proteasome activator 1 is an effective activator of the 20S protease, with IC50 values of 0.3 μM, 0.7 μM and 1.8 μM for trypsin-like sites, chymotrypsin-like sites and caspase-like sites respectively. It can be translated in cellular systems to prevent accumulation of pathogenic A53T mutant alpha-synuclein. 20S Proteasome activator 1 can be used for research on neurodegenerative diseases.

    20S Proteasome activator 1  Chemical Structure
  29. GC64472 20S Proteasome-IN-1 20S Proteasome-IN-1 is a 26S proteasome inhibitor extracted from patent WO2006128196A2 compound 2. 20S Proteasome-IN-1  Chemical Structure
  30. GC35112 3'-Hydroxypterostilbene 3'-Hydroxypterostilbene is a Pterostilbene analogue. 3'-Hydroxypterostilbene inhibits the growth of COLO 205, HCT-116 and HT-29 cells with IC50s of 9.0, 40.2 and 70.9 ?M, respectively. 3'-Hydroxypterostilbene significantly down-regulates PI3K/Akt and MAPKs signaling pathways and effectively inhibits the growth of human colon cancer cells by inducing apoptosis and autophagy. 3'-Hydroxypterostilbene can be used for the research of cancer. 3'-Hydroxypterostilbene  Chemical Structure
  31. GC12791 3,3'-Diindolylmethane


    A phytochemical with antiradiation and chemopreventative effects 3,3'-Diindolylmethane  Chemical Structure
  32. GC10710 3-Methyladenine


    3-Methyladenine is a classic autophagy inhibitor.

    3-Methyladenine  Chemical Structure
  33. GC32767 3BDO


    A butyrolactone derivative and autophagy inhibitor 3BDO  Chemical Structure
  34. GC39658 4,4'-Dimethoxychalcone 4,4'-Dimethoxychalcone acts as a natural autophagy inducer with anti-ageing properties. 4,4'-Dimethoxychalcone  Chemical Structure
  35. GC42414 4-hydroxy Tolbutamide 4-hydroxy Tolbutamide is a cytochrome P450 2C8 (CYP2C8) and CYP2C9 metabolite of tolbutamide, a first-generation potassium channel blocker. 4-hydroxy Tolbutamide  Chemical Structure
  36. GC35132 4-Hydroxylonchocarpin 4-Hydroxylonchocarpin is a chalcone compound from an extract of Psoralea corylifolia. 4-Hydroxylonchocarpin  Chemical Structure
  37. GC13104 4E1RCat

    eIF4E/eIF4G Interaction Inhibitor II

    Dual inhibitor of eIF4E:eIF4G and eIF4E:4E-BP1 interaction 4E1RCat  Chemical Structure
  38. GC30785 4E2RCat 4E2RCat is an inhibitor of eIF4E-eIF4G interaction with an IC50 of 13.5 μM. 4E2RCat  Chemical Structure
  39. GC10468 4EGI-1

    eIF4E/eIF4G Interaction Inhibitor

    Competitive eIF4E/eIF4G interaction inhibitor 4EGI-1  Chemical Structure
  40. GC25019 5-amino-2,4-dimethylpyridine (5A-DMP) 5-amino-2,4-dimethylpyridine (5A-DMP)  Chemical Structure
  41. GC65668 5-Amino-8-hydroxyquinoline


    5-Amino-8-hydroxyquinoline (5A8HQ), a potential anticancer candidate, has promising proteasome inhibitory activity. 5-Amino-8-hydroxyquinoline  Chemical Structure
  42. GC45356 5-Aminolevulinic Acid (hydrochloride)   5-Aminolevulinic Acid (hydrochloride)  Chemical Structure
  43. GC10946 5-Azacytidine

    Antibiotic U 18496, 5AzaC, Ladakamycin, Mylosar, NSC 102816, NSC 103627, U 18496, WR 183027

    A DNA methyltransferase inhibitor

    5-Azacytidine  Chemical Structure
  44. GN10241 5-Methoxypsoralen

    5-Methoxypsoralen, 5-MOP, Heraclin, NSC 95437

    5-Methoxypsoralen  Chemical Structure
  45. GC16267 6-Hydroxydopamine hydrobromide

    6-hydroxy Dopamine, Oxidopamine, 2,4,5-Trihydroxyphenethylamine

    Oxidopamine (6-OHDA) hydrobromide is an antagonist of the neurotransmitter dopamine. 6-Hydroxydopamine hydrobromide  Chemical Structure
  46. GN10228 6-Shogaol

    A bioactive component of ginger

    6-Shogaol  Chemical Structure
  47. GC12739 A 484954 A eukaryotic elongation factor-2 (eEF-2) kinase inhibitor A 484954  Chemical Structure
  48. GC17710 A-317491

    A 317491;A317491

    A P2X3 and P2X2/3 receptor antagonist A-317491  Chemical Structure
  49. GC35211 A-317491 sodium salt hydrate A-317491 sodium salt hydrate is a potent, selective and non-nucleotide antagonist of P2X3 and P2X2/3 receptors, with Kis of 22, 22, 9, and 92 nM for hP2X3, rP2X3, hP2X2/3, and rP2X2/3, respectively. A-317491 sodium salt hydrate  Chemical Structure
  50. GC15014 A-867744 A positive allosteric modulator of α7 nAChRs A-867744  Chemical Structure
  51. GC11200 A23187


    A23187, free acid is a Ca2+ ionophore

    A23187  Chemical Structure
  52. GC14069 ABT-199

    GDC 0199, Venetoclax

    A Bcl-2 inhibitor ABT-199  Chemical Structure
  53. GC17234 ABT-737

    ABT 737, ABT737

    An inhibitor of anti-apoptotic Bcl-2 proteins ABT-737  Chemical Structure
  54. GC15875 ABT-751 (E7010) ABT-751 (E7010)(E 7010) is a novel bioavailable tubulin-binding and antimitotic sulfonamide agent with IC50 of about 1.5 and 3.4 μM in neuroblastoma and non-neuroblastoma cell lines, respectively. ABT-751 (E7010)  Chemical Structure
  55. GC12422 ABT-888 (Veliparib) ABT-888 (Veliparib)  Chemical Structure
  56. GC10871 AC 55649 RARβ2 agonist, potent and selective AC 55649  Chemical Structure
  57. GC42685 Ac-ANW-AMC


    Ac-ANW-AMC is a fluorogenic substrate for the β5i/LMP7 subunit of the 20S immunoproteasome.

    Ac-ANW-AMC  Chemical Structure
  58. GC42710 Ac-PAL-AMC

    Acetyl-Pro-Ala-Leu-7-amino-4-Methylcoumarin, Ac-Pro-Ala-Leu-AMC

    Ac-PAL-AMC is a fluorogenic substrate for the β1i/LMP2 subunit of the 20S immunoproteasome. Ac-PAL-AMC  Chemical Structure
  59. GC42720 Ac-WLA-AMC

    Acetyl-Trp-Leu-Ala-7-amino-4-Methylcoumarin, Ac-Trp-Leu-Ala-AMC

    Ac-WLA-AMC is a fluorogenic substrate for the β5c subunit of the 20S proteasome. Ac-WLA-AMC  Chemical Structure
  60. GC35228 Aceglutamide

    Aceglutamide, Acetylglutamine, N-acetyl Gln, NSC 186896

    Aceglutamide (α-N-Acetyl-L-glutamine) is a psychostimulant and nootropic, used to improve memory and concentration. Aceglutamide  Chemical Structure
  61. GC11567 Acetazolamide

    L-579,486, NSC 145177

    carbonic anhydrase (CA) inhibitor

    Acetazolamide  Chemical Structure
  62. GC14142 Acetylcholine Chloride


    Major transmitter at many nervous sites Acetylcholine Chloride  Chemical Structure
  63. GC17094 Acitretin

    all-trans Acitretin, Ro 10-1670, Ro 10-1670/000

    Metabolite of etretinate

    Acitretin  Chemical Structure
  64. GC17113 Acitretin sodium Second-generation, systemic retinoid Acitretin sodium  Chemical Structure
  65. GC10102 Aclacinomycin A

    NSC 208734

    An anthracycline with antibiotic and anticancer activities Aclacinomycin A  Chemical Structure
  66. GC35238 Aclacinomycin A hydrochloride Aclacinomycin A hydrochloride (Aclarubicin hydrochloride), a fluorescent molecule and the first described non-peptidic inhibitor showing discrete specificity for the CTRL (chymotrypsin-like) activity of the 20S proteasome. Aclacinomycin A hydrochloride is also a dual inhibitor of topoisomerase I and II. An effective anthracycline chemotherapeutic agent for hematologic cancers and solid tumors. Aclacinomycin A hydrochloride  Chemical Structure
  67. GC41242 Acridine Orange

    NSC 194350

    Acridine Orange is a cell-penetrating, nucleic acid-selective fluorescent dye.

    Acridine Orange  Chemical Structure
  68. GC35242 Actein Actein is a triterpene glycoside isolated from the rhizomes of Cimicifuga foetida. Actein suppresses cell proliferation, induces autophagy and apoptosis through promoting ROS/JNK activation, and blunting AKT pathway in human bladder cancer. Actein has little toxicity in vivo. Actein  Chemical Structure
  69. GC16866 Actinomycin D

    Cosmegen, Dactinomycin, Meractinomycin, NCI C04682, NSC 3053, Oncostatin K

    A DNA-interacting transcription blocker with anti-cancer activity

    Actinomycin D  Chemical Structure
  70. GC19019 Acumapimod


    Acumapimod (BCT197) is an orally active p38 MAP kinase inhibitor, with an IC50 of less than 1 uM for p38α. Acumapimod  Chemical Structure
  71. GC10610 Adapalene

    CD 271

    RARβ and RARγ agonist Adapalene  Chemical Structure
  72. GC14379 Adapalene sodium salt Retinoic acid receptor agonist Adapalene sodium salt  Chemical Structure
  73. GC14106 Adenosine

    NSC 7652

    nucleoside Adenosine  Chemical Structure
  74. GC19729 Adenosine 5′-diphosphoribose sodium

    ADP ribose sodium

    Adenosine 5′-diphosphoribose sodium (ADP ribose sodium) is a nicotinamide adenine nucleotide (NAD+) metabolite. Adenosine 5′-diphosphoribose sodium  Chemical Structure
  75. GC10707 Afatinib dimaleate

    Afatinib dimaleate, BIBW 2992, BIBW 2992MA2

    An inhibitor of EGFR and ErbB2 Afatinib dimaleate  Chemical Structure
  76. GC60567 Afatinib impurity 11 Afatinib impurity 11 is an impurity of Afatinib. Afatinib is an irreversible EGFR family inhibitor with IC50s of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively. Afatinib impurity 11  Chemical Structure
  77. GC35262 Afzelin

    Kaempferin, Kaempferol 3-O-rhamnoside, Kaempferol 3-O-α-L-rhamnopyranoside

    A polyphenolic glycoside flavone with diverse biological activities Afzelin  Chemical Structure
  78. GC13697 AG-1024

    AGS 200, Tyrphostin AG1024

    Selective IGF-1R inhibitor AG-1024  Chemical Structure
  79. GC13854 AG-490 (Tyrphostin B42)

    Tyrphostin AG-490

    AG-490 (Tyrphostin B42) (Tyrphostin AG-490 (Tyrphostin B42)) is a tyrosine kinase inhibitor that inhibits EGFR, Stat-3 and JAK2/3. AG-490 (Tyrphostin B42)  Chemical Structure
  80. GC32817 AGN 193109 AGN 193109 is a retinoid analog, and acts as a specific and highly effective antagonist of retinoic acid receptors (RARs), with Kds of 2 nM, 2 nM, and 3 nM for RARα, RARβ, and RARγ, respectively. AGN 193109  Chemical Structure
  81. GC33315 AGN 194078 AGN 194078 is a selective RARα agonist with a Kd and EC50 of 3 and 112 nM, respectively. AGN 194078  Chemical Structure
  82. GC12598 AGN 194310


    pan-RAR antagonist AGN 194310  Chemical Structure
  83. GC35265 AGN 195183

    IRX-5183; VTP-195183; NRX-195183

    AGN 195183 (IRX-5183) is a potent and selective agonist of RARα (Kd=3 nM) with improved binding selectivity relative to AGN 193836. AGN 195183 has no activity on RARβ/γ. AGN 195183  Chemical Structure
  84. GC35266 AGN 196996 AGN 196996 is a potent and selective RARα antagonist with Ki value of 2 nM; little binding affinity for RARβ(Ki=1087 nM) and RARγ(Ki=8523 nM). AGN 196996  Chemical Structure
  85. GC35267 AGN 205327 AGN 205327 is a potent synthetic RARs agonist with EC50 of 3766/734/32 nM for RARα/β/γ respectively; no inhibition on RXR. AGN 205327  Chemical Structure
  86. GC35268 AGN 205728 AGN 205728 is a potent and selective RARγ antagonist with Ki/IC95 values of 3 nM/ 0.6 nM; no inhibiton on RARα and RARβ. AGN 205728  Chemical Structure
  87. GC10518 AICAR

    Acadesine, AICA-Riboside, NSC 105823

    An activator of AMPK

    AICAR  Chemical Structure
  88. GC10580 AICAR phosphate AMPK activator AICAR phosphate  Chemical Structure
  89. GC12646 AL 8697 p38α inhibitor,potent and selective AL 8697  Chemical Structure
  90. GC33743 Alicapistat (ABT-957)


    Alicapistat (ABT-957) (ABT-957) is an orally active selective inhibitor of human calpains 1 and 2 for the potential application of Alzheimer's disease (AD). Alicapistat (ABT-957)  Chemical Structure
  91. GC15451 Aliskiren Aliskiren  Chemical Structure
  92. GC13223 Aliskiren Hemifumarate

    CGP 60536, SPP 100

    renin inhibitor Aliskiren Hemifumarate  Chemical Structure
  93. GN10407 Alisol A Alisol A  Chemical Structure
  94. GC14749 ALLO-1 ALLO-1, an autophagy receptor, is essential for autophagosome formation around paternal organelles and directly binds to the worm LC3 homologue LGG-1 through its LC3-interacting region (LIR) motif. ALLO-1  Chemical Structure
  95. GN10516 Aloeemodin

    3-Hydroxymethylchrysazine, NSC 38628, Rhabarberone

    Aloeemodin  Chemical Structure
  96. GC14314 Aloperine An alkaloid Aloperine  Chemical Structure
  97. GC13789 AM 114

    PS-IX; AM114

    AM 114  Chemical Structure
  98. GC13664 AM580

    CD336, NSC 608001, Ro 406055

    Selective RARα agonist AM580  Chemical Structure
  99. GC35322 Amiodarone Amiodarone is an antiarrhythmic drug for inhibition of ATP-sensitive potassium channel with an IC50 of 19.1 μM. Amiodarone  Chemical Structure
  100. GC11432 Amiodarone HCl Amiodarone HCl, a benzofuran-based Class III antiarrhythmic agent, inhibits WT outwardIhERG tails with an IC50 of ~45 nM. Amiodarone HCl  Chemical Structure
  101. GC63316 Ammonium chloride Ammonium chloride, as a heteropolar compound with pH value regulation, can cause intracellular alkalization and metabolic acidosis thus effecting enzymatic activity and influencing the process of biological system. Ammonium chloride is an autophagy inhibitor. Ammonium chloride  Chemical Structure

Items 1 to 100 of 1182 total

per page
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Descending Direction